Allergan News

A recent selloff in specialty pharmaceuticals has creating a buying opportunity, according to Goldman Sachs analyst Gregory Waterman , but he thinks investors should be discriminating.

Stocks around the globe have been taking a hit during the month of May, which has pushed the major stock indexes into oversold territory.

May 21, 2012 News Watch via COMTEX) -- When Allergan reported earnings two weeks ago on May 2nd, 2012, analysts, on average, expected the company to report earnings of $0.87 on sales of $1.4 billion.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Allergan, which makes Botox, will build a nearly $12 million research and development facility in Bridgewater, the company and the site's owner, SJP Properties, announced ... (more)

Join the thousands of real estate professionals that subscribe to the New Jersey AM Alert.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia The cost regulator for the U.K.'s publicly-funded National Health Service has reversed its earlier stance on U.S.-based Allergan Inc.'s wrinkle-fighting drug Botox and now ... (more)

Both have exceptional track records in the biotechnology industry and bring a wealth of ophthalmology experience to Amakem.

Health watchdog the National Institute for Health and Clinical Excellence has published final draft guidance which recommends the anti-wrinkle jab for the condition.

Apple Inc. : Jim Cramer ranked this stock a Buy . The stock closed at $569.18, its 52-week high is $644.00, and its 52-week low is $310.50. Allergan Inc.

In an EU row over trademarks, Helena Rubinstein and L'Oreal have been told to withdraw their brands "Botolist" and "Botocyl" respectively.

Apple , Starbucks , Chipotle Mexican Grill , Ross Stores , Allergan , Celgene , Lululemon .

ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the first quarter ended March 31, 2012.

Wall St. Watchdog reveals information about insider trades in the constituent companies of the S&P 500 for May 4th.

Allergan Inc. , the maker of the wrinkle treatment Botox, received a U.S. government subpoena over its gastric banding device for obesity.

's stock had its "neutral" rating reiterated by Zacks in a research note issued to investors on Friday.

Shares of Smith & Nephew rise sharply as its first quarter trading profit, boosted by knee replacements and wound care, of $252 million compared to $241 million year-to-year becomes known.

On Wednesday, Allergan, Inc. reported its first quarter earnings and discussed the following topics in its earnings conference call.

The analysts wrote, "AGN reported 1Q revs slightly above the Street, but EPS a penny below consensus, and guided to 2Q below expectations while maintaining full-year guidance.

American Express Company maintained its quarterly dividend of 20 cents per share.

Allergan Inc.'s first-quarter earnings rose 45% as the maker of Botox and medical devices reported double-digit sales growth at its specialty pharmaceuticals business.